NEW YORK (GenomeWeb) – Private investment fund StoneCalibre today announced the acquisition of DNA sequencing consumables firm Edge Biosystems for an undisclosed amount.
Based in Gaithersburg, Md., EdgeBio manufactures and distributes sample preparation and clean-up products for DNA sequencing. Its products are used in clinical and diagnostic laboratories, food testing, molecular medicine, ancestry studies, and other applications. The company was founded in 1990.
Last year, EdgeBio sold its next-generation sequencing service business to GeneDx, while it retained its product business, which includes reagents for sequencing clean up, PCR purification, sample prep, and competent cells for cloning applications.
"We believe EdgeBio will continue to build on its tradition of providing high-quality, easy-to-use products to its global customer base and serve as a strong platform for future growth," StoneCalibre Founder and CEO Brian Wall said in a statement.